Start Here — Tell Us About You

• What's your main reason for reaching out today? Options: Trying to conceive (IVF/IUI), Egg freezing (fertility preservation), Seeking evaluation after infertility diagnosis, Second opinion, Employer benefits inquiry, Other
• When did you first notice difficulty conceiving or decide fertility care was needed? Options: Less than 6 months ago, 6–12 months ago, 12–24 months ago, 24+ months ago, Immediate due to age or diagnosis, Other
• Who referred you or encouraged you to pursue specialized fertility care? Options: OB/GYN, Primary care provider, Friend or family member, Employer/benefits manager, Self-referred, Other
• Are you pursuing this alone or with a partner/co-parent? How involved will others be in decision-making? Options: Me alone, Partner/spouse (shared decisions), Partner will be involved but not primary decision-maker, Co-parent/other, Undecided
• Please tell us about any previous fertility tests, treatments, or surgeries (include dates and any outcomes you remember).
• How urgent does this feel to you right now? Options: Very urgent (within months), Somewhat urgent (3–6 months), Not urgent (6–12+ months), Unsure
• What is the single most important outcome you hope we prioritize in our first conversation? Options: Understand my diagnostics and options, Estimate realistic success and timeline, Clarify costs and insurance, Create a next-step plan, Emotional support / counseling, Other

Was There a Moment That Changed Everything?

• Was there a single test, appointment, or failed attempt that made you think routine care wasn't enough? Options: Yes—a specific test or result, Yes—a failed treatment cycle, No—slow decline over time, Not sure
• How long has this specific issue persisted, and how has it evolved? Options: Under 6 months, 6–12 months, 1–3 years, 3+ years, Variable/episodic
• Which diagnostic tests have you completed? Select all that apply and add details below. Options: AMH (antimullerian hormone), FSH/LH/estradiol, Day 3 hormone panel, Transvaginal ultrasound (antral follicle count), Hysterosalpingogram (HSG), Semen analysis, Genetic carrier screening, Other / not sure
• Has your referring clinician given a specific diagnosis (e.g., diminished ovarian reserve, unexplained infertility, male factor, tubal disease, endometriosis)? If yes, what was said? Options: Diminished ovarian reserve, Unexplained infertility, Male factor infertility, Tubal factor, PCOS, Endometriosis, Other, No diagnosis given
• Have you undergone prior assisted cycles (IUI, IVF) or fertility-related surgeries? Describe outcomes and any emotional impact.
• Which specific numbers or results (AMH value, sperm concentration, prior egg/retrieval counts) have stayed with you?
• How well do you feel you understood the medical explanation you were given? Options: Completely, Mostly, Somewhat, Not at all
• What part of your diagnosis or previous conversations felt most confusing or concerning?

What Keeps You Up at Night About This?

• If you imagine the worst-case scenario of this journey, what is the single thing you fear most? Options: Never achieving a live birth, Losing significant time/opportunity due to age, Emotional toll of repeated failures, Financial ruin/overwhelm, Medical complications/side effects, Other
• How do financial concerns influence what you feel you can try? Options: Major barrier—likely prevents treatment, Significant concern—needs planning, Manageable with financing or benefits, Not a major factor right now, Unsure
• If you had to give a comfortable out-of-pocket range per IVF cycle, what would it be? Options: Under $5,000, $5,000–$10,000, $10,000–$20,000, $20,000+, Unsure / need counseling
• How much do worries about medication side effects, procedures, or recovery affect your willingness to move forward? Options: Severely—may decline treatment, Moderately—would need reassurance, Slightly—manageable, Not at all
• How concerned are you about multiple pregnancies and a clinic's embryo transfer policy? Options: Very concerned—require single-embryo transfer, Somewhat concerned, Neutral, Prefer more than one embryo if it raises chances, Unsure
• Emotionally, what has helped you cope so far and who are your support people?
• Have prior experiences made you distrust clinics or pushed non-negotiables (e.g., lab transparency, single-embryo transfer)? Please list. Options: Require lab success data, Require single-embryo transfer policy, Require counseling support, PGT mandatory, No non-negotiables, Other

If We Could Guarantee One Thing, What Would It Be?

• If you could guarantee one outcome from treatment, what would you choose? Options: Healthy singleton live birth, Any live birth regardless of multiples, Bank a specific number of mature eggs, Obtain genetically-normal embryos (PGT), Confirm pregnancy quickly and naturally, Other
• How many children would feel like success to you (short answer if you're unsure)? Options: One, Two, Three or more, Unsure / depends, Not applicable—egg freezing only
• How important is genetic testing of embryos (PGT-A or PGT-M) to your decision-making? Options: Essential, Preferred but not required, Open to discuss, Prefer not to use, Unsure
• Would you accept a plan that prioritizes safety and a later frozen embryo transfer over a fresh transfer if it increases chances of a healthy singleton birth? Options: Yes—safety and outcome first, Maybe—need explanation, Prefer fresh transfer, Unsure
• Describe what a 'successful, respectful, and transparent' clinic experience looks like to you—what signals would make you feel confident?
• Are you more focused on absolute success rates, the clinic's approach to embryo care, or emotional support during treatment? Options: Clinical success rates, Embryology lab protocols and quality, Emotional and counseling support, All equally important, Other

Who Else Needs to Be Comfortable With This?

• Whose approval, information, or benefits confirmation will make or break this plan for you? Options: Partner/spouse, Referring OB/GYN, Employer/benefits manager, Insurance company, Family members, Donor or surrogate, Legal advisor, Other
• Who will be the primary signer of medical consents and who will make final medical decisions if there's disagreement? Options: Me, Partner, Both together, Legal guardian/POA, Undecided
• Have you discussed this with your employer or benefits manager? Do you have documented fertility coverage? Options: Yes—documented coverage, Yes—verbal only, No, Unsure
• If you selected documented coverage, please briefly summarize what's covered (cycles, diagnostics, limits) or paste a plan excerpt.
• Are there cultural, religious, or family expectations that could rule certain options in or out (donor use, embryo disposition, surrogacy)? Options: Yes, No, Unsure
• What scheduling constraints (work, caregiving, travel) could limit when we can perform stimulation, retrieval, or transfer? Options: Work schedule restrictions, Caregiving responsibilities, School or childcare, Regular travel, No major constraints, Other

What Are You Willing to Try — and What’s Off the Table?

• If progress toward your goal required a step you currently worry about (donor eggs, PGT, surgery), how open are you to that trade-off? Options: Very open if it raises chances, Open with clear rationale and risks, Reluctant but may consider, Not open
• Which treatment pathways are you open to right now? Select all that apply. Options: IUI (intrauterine insemination), IVF with own eggs, IVF with donor eggs, Egg freezing (oocyte cryopreservation), Surgical correction (e.g., laparoscopy), PGT (genetic testing of embryos), Third-party reproduction (surrogacy), Natural cycle / minimal stimulation, Unsure / need discussion
• Are there any procedures, technologies, or donor arrangements you would categorically refuse? Please describe.
• Do you have preferences about clinic or lab standards (local clinic vs traveling, lab accreditation, single-embryo transfer policies)? Options: Prefer local clinic, Willing to travel for higher success, Require accredited lab (SART/CDC/HFEA), Require strict single-embryo transfer policy, No strong preference, Other
• How many treatment cycles are you emotionally and financially prepared to attempt before stopping or pivoting? Options: One, 2–3, 4–6, Open depending on results, Unsure
• What specific outcome or event would make you stop, take a break, or change course?
• Would you consider fertility preservation now (egg-freezing) even if you plan pregnancy later? If yes, how many eggs would you hope to bank? Options: Yes—goal 10+ eggs, Yes—goal 6–9 eggs, Yes—goal 1–5 eggs, Maybe, No, Already frozen

Practical Constraints, Insurance, and Next Steps

• If insurance denied coverage tomorrow, which would you most likely do? Options: Pause and re-evaluate, Proceed out-of-pocket, Seek a different clinic or advocate with HR/insurer, Pursue lower-cost options like IUI, Unsure
• Do you currently have prior authorization or pre-approval documentation for fertility services? Options: Yes—fully approved, Partial/conditional approval, Awaiting approval, No, Unsure
• When would you ideally like to begin active treatment (stimulation/retrieval/first IUI)? Options: Within 30 days, 1–3 months, 3–6 months, 6+ months, Undecided
• What supports would make it easier to start—select all that apply? Options: Financial counseling and cost estimates, Flexible appointment times (evening/weekend), Nurse navigator/concierge support, Telemedicine for follow-ups, Mental health counseling/support group, Payment plans or financing, Travel coordination
• What are your top 2–3 questions or deal-breakers we should address before booking a consult?
• Who should our scheduling team contact to set the next appointment and what's the best contact method and availability? Options: Me—phone, Me—email, Me—text, Partner—phone, Partner—email, Other
• Is there any additional context—medical, emotional, financial, or legal—you want the care team to know before the consult?

• Diagnostic Review & Current-State Confirmation
• Consequence & Goals Quantification
• Pathway Experience — Personalized Treatment Walkthroughs
• Financial & Benefits Alignment (Pathway-specific)
• Validation & Mutual Commit — Pre-Treatment Checklist

• Create transparency around financial contingencies that could change the plan.
• If requested, schedule a separate counseling session (psychological/support) and provide resources on emotional support.
• Restate Future-State Objective
• Provide evidence that a defined future state is achievable under at least one personalized pathway.
• Obtain patient confirmation on preferred pathway(s) to progress toward pre-treatment steps.
• Identify any remaining clinical or logistical blockers that would prevent executing the preferred pathway.
• Document selected pathway(s) in the journey and list required pre-treatment orders and timelines.
• Provide the patient with the analogue case-study pamphlet and tailored probability summary for their records.
• If pathway requires PGT or special lab protocol, flag the lab and embryology team and confirm capacity and scheduling constraints.
• Recap Chosen Pathway(s) & Expected Outcomes
• Ensure patient can make an informed decision with a clear, pathway-specific financial picture.
• Secure agreement on payment structure or next steps to resolve benefits gaps before pre-treatment.
• Introductions & Meeting Objective
• Finalize and upload a pathway-specific cost estimate and financial agreement to the shared workspace.
• Submit any required pre-authorizations or benefit appeals and track responses.
• If payment plan selected, enroll patient and schedule first payment milestone.
• One-Sentence Future-State Confirmation
• Mutual commitment to the treatment start window with owners and measurable milestones assigned.
• All pre-treatment requirements completed or scheduled with deadlines and responsible parties.
• Clear contingency plans are recorded and accepted by patient and care team.
• Lock treatment dates in the clinic scheduling system and notify all owners.
• Capture electronic informed consent and financial acknowledgement in the patient record.
• Create and assign a contingency task list for potential blockers (e.g., low response, insurance denial) with owners and SLAs.
• Produce an agreed one-sentence current-state summary that all participants confirm.
• Identify and assign ownership for all missing diagnostics and records required for reliable treatment planning.
• Confirm patient constraints and stakeholders that will influence pathway choices.
• Order or request missing tests (list specific labs/imaging) and set deadlines for completion.
• Upload consolidated diagnostic packet and the one-sentence current-state summary to the shared journey workspace.
• Obtain patient authorization to share records with referring physicians and benefits manager if required.
• Recap Current State & Problem Statement
• Make the consequence of inaction or suboptimal choice explicit in money, time, and clinical risk terms.
• Agree on the patient's risk tolerance and timeline priorities to guide pathway selection.
• Produce measurable targets for the desired future state (e.g., target live-birth probability within X months).
• Generate a personalized comparison sheet showing probabilities, timelines, and cost-to-success for each considered pathway.
• Document patient’s stated risk tolerance and target timeline in the journey record.
• One-Sentence Current-State Statement
• Benefits Verification Summary
• Pathway A Walkthrough (e.g., IVF + PGT)
• Probability Estimates by Pathway
• Pre-treatment Requirements Checklist
• Schedule, Owners & Milestones
• Pathway B Walkthrough (e.g., IUI or Conservative IVF)
• Cost-to-Success and Contingency Scenarios
• Quantify Time and Financial Consequences
• Structured Diagnostic Walkthrough
• Gap Identification & Required Pre-work
• Payment Options & Financial Policies
• Emotional & Clinical Risk Scenarios
• Contingency & Escalation Paths
• Pathway C Walkthrough (e.g., Egg-Freezing/Deferred Transfer)
• Tight Problem-to-Solution Mapping
• Final Validation & Signatures
• Patient Priorities & Constraints
• Trade-off Discussion & Risk Tolerance Check
• Decision & Financial Consent
• Agree Next Administrative Steps
• Validation Checkpoints & Decision Criteria

• Administer ovarian stimulation medications
• Perform transvaginal oocyte retrieval
• Process and prepare sperm samples
• Perform conventional IVF fertilization
• Perform intracytoplasmic sperm injection (ICSI)
• Culture embryos to blastocyst stage
• Trophectoderm biopsy for PGT-A
• Run PGT-A genetic analysis
• Vitrify (cryopreserve) oocytes and embryos
• Warm embryos and perform frozen embryo transfer
• Perform single-embryo transfer under ultrasound
• Provide luteal phase hormonal support
• Intrauterine insemination (IUI) procedure

Administer ovarian stimulation medications

• What stimulation protocol are you considering? Options: Antagonist (GnRH antagonist), Long Agonist (GnRH agonist), Mild/Minimal Stimulation, Natural cycle, Unsure / Need recommendation
• What is the intended start timing relative to patient's cycle or baseline testing? Options: Immediate (within 1 week), Next menstrual cycle, After additional diagnostics, Timing flexible / patient preference
• Are there specific contraindications or comorbidities affecting medication choice (e.g., PCOS, OHSS risk, thromboembolic disease)?
• Do you require home delivery or clinic dispensing of stimulation medications and training? Options: Clinic pick-up with in-person teaching, Home delivery with remote training, Patient already comfortable with injections, Not sure
• What monitoring intensity is expected for this stimulation (US + labs frequency)? Options: Standard (3–5 visits per cycle), Intensive (5+ visits per cycle), Minimal monitoring, Unsure—please advise
• Are there medication cost or insurance coverage constraints we should account for when selecting drugs? Options: Yes, cost-sensitive, No restrictions, Insurance requires prior authorization, Unknown

Perform transvaginal oocyte retrieval

• Do you have anesthesia preference for retrieval? Options: General anesthesia, MAC / IV sedation, Local with sedation, Patient preference to discuss
• What is the expected window for scheduling retrieval (dates or follicle criteria)?
• Are there surgical or bleeding risk factors (e.g., anticoagulation, prior pelvic surgery) to flag? Options: Yes - specify in notes, No known risk factors, Unknown - need evaluation
• What follicle/estradiol trigger criteria will be used to proceed with retrieval? Options: >=3 follicles >=17mm, Individualized follicle/estradiol thresholds, Trigger based on provider judgment, Other
• Do you require same-day post-op instructions, transport support, or extended recovery observation? Options: Standard discharge, Requires extended observation, Needs transport arranged, Unsure
• Are there specimen handling preferences (immediate to lab, labeling, partner presence for sample drop-off)?

Process and prepare sperm samples

• What is the sperm source for this cycle? Options: Partner (ejaculate), Donor (anonymous/known), Surgically retrieved (TESE/MESA), Unknown / to be determined
• If partner ejaculate, what is the expected abstinence interval (days)? Options: 1–2 days, 2–5 days, 5+ days, Unknown
• Are there known infectious disease results or screening requirements for the sample? Options: Yes - positive/needs details, All screens negative, Pending results, Not required (donor with certificate)
• Which sperm processing method is preferred or required? Options: Density gradient centrifugation, Swim-up, Direct wash / simple prep, ICSI prep (special handling)
• Do you want aliquots cryopreserved or surplus samples banked? Options: Yes - cryopreserve aliquot, No, Depends on sample quality, Discuss with lab
• Are special assays needed (e.g., DNA fragmentation testing, CASA report)? Options: Yes - specify, No, Maybe - recommend if abnormal semen

Perform conventional IVF fertilization

• Is conventional IVF the planned fertilization method for this cycle? Options: Yes, No—ICSI planned, Conditional (depends on semen analysis), Undecided
• What insemination concentration and incubation period do you prefer for conventional IVF? Options: Standard insemination concentration, Low sperm concentration protocol, Timed insemination / immediate check, Follow lab standard
• Do you require assisted hatching or other adjuncts at fertilization or cleavage check? Options: Yes - assisted hatching, No, Only if indicated, Unsure
• What is the contingency plan if fertilization rates are low (e.g., convert to ICSI, repeat cycle)? Options: Convert to ICSI same cycle if available, Plan for repeat cycle, Discuss options at time of result, Other
• What timing do you want for fertilization checks and reporting (e.g., 16–18 hrs post-insemination)? Options: Standard 16–18 hours, Early check + 16–18 hours, Custom timing—specify, Follow lab default
• Are there specific documentation or consent requirements related to fertilization method? Options: Yes - written consent for method, No special requirements, Need to review with patient

Perform intracytoplasmic sperm injection (ICSI)

• What are the indications for ICSI in this case? Options: Severe male factor, Prior fertilization failure with conventional IVF, PGT required, Elective / clinic policy, Other
• What sperm source will be used for ICSI? Options: Fresh ejaculate, Frozen partner, Donor sperm, Testicular / epididymal sample (TESE/MESA)
• How many mature (MII) oocytes should be targeted for microinjection? Options: Inject all MII oocytes, Limit to X oocytes (specify in notes), Discuss on day with lab
• Are there lab or operator preferences for ICSI technique (conventional ICSI vs. IMSI)? Options: Conventional ICSI, IMSI / high-magnification, Depends on sperm quality, No preference
• Do you require documentation of injected oocytes and injection time-stamps for records? Options: Yes - detailed records, Standard lab record, No special requirements
• Is additional patient consent required for ICSI and related risks? Options: Yes - signed consent on file, No - included in general consent, Consent pending

Culture embryos to blastocyst stage

• Do you plan extended culture to blastocyst (Day 5/6) for all embryos? Options: Yes - extend all viable embryos, Selective extension based on cleavage-stage outcome, No - freeze/transfer earlier, Undecided
• Which culture system or incubator preferences should lab follow (time-lapse imaging, standard incubator)? Options: Time-lapse (Embryoscope), Standard benchtop incubator, Other - specify, Follow lab standard
• Do you want morphokinetic analysis or additional grading criteria applied during culture? Options: Yes - morphokinetics, No - standard morphology grading, Only if available
• What are the thresholds for proceeding to biopsy or cryopreservation at blastocyst? Options: Any blastocyst meeting quality threshold, Minimum grade required (specify), Only fully expanded blastocysts, Discuss case-by-case
• Should surplus good-quality embryos be prioritized for vitrification or re-culture? Options: Vitrify surplus blastocysts, Re-culture another day, Decide after consensus with team/patient
• Are there special media or supplements the lab should avoid or include (e.g., patient allergies to additives)?

Trophectoderm biopsy for PGT-A

• Will trophectoderm biopsy for PGT-A be performed on all blastocysts or only selected embryos? Options: All blastocysts, Selected blastocysts only, Do not plan biopsy, Undecided
• What biopsy policy should be followed regarding cell number and technique? Options: Standard 5–10 cells, Minimal cell removal, Clinic default technique, Specify alternative
• How should mosaicism results be managed (transfer policy for low/high mosaic embryos)? Options: Prefer euploid only, Allow low-level mosaic with counseling, Case-by-case with genetics consult, Undecided
• Have patients provided informed consent specifically for biopsy and potential embryo disposition outcomes? Options: Yes - consent on file, No - consent pending, Need to schedule counseling
• Do you require embryo cryopreservation before biopsy or after biopsy only? Options: Cryopreserve post-biopsy, Freeze before biopsy, Either is acceptable, Follow lab standard
• Are there scheduling constraints for biopsy-to-shipping timelines based on chosen PGT lab? Options: Yes - tight courier window, No - flexible, Dependent on lab partner

Run PGT-A genetic analysis

• Which PGT-A laboratory or platform should be used (if specified)? Options: Preferred external lab (specify), In-house NGS platform, Lab to recommend, Undecided
• What turnaround time is required for PGT-A results? Options: Standard (7–14 days), Expedited (3–7 days), No rush / flexible, Unknown
• Are parental samples (blood/saliva) required or already submitted for lab pairing? Options: Yes - submitted, Yes - need to collect, No - not required, Unknown
• Do you require additional analyses (e.g., parental carrier screening cross-check, microarray vs NGS)? Options: Yes - specify, No, Only if indicated
• Who is responsible for ordering prior authorization and insurance claims for PGT-A? Options: Clinic genetic counselor, Financial counselor/patient, External lab handles, Unsure
• What reporting format and counseling support do you expect with results (e.g., genetics consult included)? Options: Detailed lab report + genetics consult, Standard report only, Summarized for patient, Other

Vitrify (cryopreserve) oocytes and embryos

• Which specimens are planned for vitrification (MII oocytes, cleavage embryos, blastocysts)? Options: MII oocytes, Cleavage-stage embryos, Blastocysts, All applicable
• What minimum quality or number thresholds trigger vitrification of embryos or oocytes? Options: Any viable embryo/oocyte, Minimum grade required (specify), Patient preference, Lab standard
• What storage duration and labeling requirements should be set (short-term vs long-term, patient ID protocols)? Options: Short-term (<=1 year), Long-term (>1 year), Patient-specified duration, Follow legal default
• Are there consent or disposition instructions for surplus frozen material (donation, discard, indefinite storage)? Options: Donate to research, Donate to others, Discard after X years, Indefinite storage, Patient will specify
• Do you require transport/shipping for cryostorage at external facility? Options: Yes - arrange shipping, No - keep on-site, Not yet determined
• Are there cost or insurance constraints affecting number of oocytes/embryos to freeze? Options: Yes - cost-sensitive, No restrictions, Insurance covers storage, Unknown

Warm embryos and perform frozen embryo transfer

• What warming survival threshold will be acceptable to proceed with transfer? Options: >=80% survival, Any surviving embryo, Depends on embryo quality, Follow lab guidance
• Which endometrial preparation protocol is planned for FET? Options: Natural cycle, Hormone replacement therapy (HRT) cycle, Modified natural with trigger, Clinic to recommend
• What embryo selection priority should be used (PGT status, morphology, patient preference)? Options: Euploid first (PGT-A), Best morphology, Patient preference, Combined criteria
• What scheduling window and backup plan if warming fails or endometrium is suboptimal? Options: Reschedule to next window, Convert to transfer of next embryo, Cancel cycle and replan, Discuss at time of event
• What luteal support protocol should be initiated pre-/post-warming for FET? Options: Vaginal progesterone, IM progesterone, Oral/combined, Follow embryo transfer section
• Do you require post-warm viability assays or time-lapse imaging after warming? Options: Yes - viability documented, No - standard visual check, Only if issues suspected

• Informed Consent
• Statement of Work (SOW)
• Financial Agreement & Fee Schedule
• Payment Authorization & Billing Consent
• Insurance & Benefits Verification Authorization
• Scheduling & Treatment Window Agreement
• Contingency & Cancellation Policy
• Cryopreservation & Storage Agreement
• Genetic Testing Authorization
• Third‑Party Donor/Recipient & Surrogacy Agreements
• HIPAA & Data Sharing Consent
• Anesthesia & Procedural Sedation Consent
• Mutual Responsibilities & Escalation Matrix
• Refund, Shared‑Risk or Success Program Agreement

• Clinical Outcome Review & Patient Validation
• Multidisciplinary Learnings & Quality Review
• Follow-up Care Coordination & Handoff
• Shared Channel Setup & Feedback / Enhancement Workflow
• Financial Reconciliation & Contingency Planning

• Establish reporting cadence so feedback informs QA and product/process improvements.
• Decide whether to update SOPs, training, or lab protocols and set review dates.
• Create a QA Case Report summarizing findings, decisions, and assigned owners within 5 business days.
• If applicable, draft SOP or protocol changes and circulate for clinical governance approval.
• Schedule follow-up to review impact metrics at the agreed date.
• Confirm Clinical Status (Current State)
• Ensure the patient has a clear, safe follow-up care plan with dates, owners, and contact points.
• Complete administrative handoffs and confirm benefits coverage for next steps.
• Connect patient with appropriate psychosocial support resources.
• Book and confirm all required follow-up appointments and send calendar invites to patient.
• Send a one-page care plan and emergency contact sheet to the patient and receiving provider.
• Initiate any required benefits authorizations and update the financial counselor on outstanding items.
• Define Purpose and Scope
• Launch a secure shared channel with clear access controls and patient consent documented.
• Agree on escalation rules, SLAs, and owners for clinical issues and enhancement requests.
• One-sentence Current State
• Provision the shared channel (portal thread or secure messaging) and send access instructions to participants.
• Publish the escalation matrix, SLAs, and submission templates to the channel and clinic intranet.
• Add the case to the monthly feedback report and schedule the first review meeting.
• One-sentence Financial Current State
• Finalize and document the patient's financial reconciliation and any refunds or credits.
• Confirm insurance/benefit outcomes and next administrative steps (appeals or re-submissions).
• Agree on contingency financing options for the patient if additional cycles are pursued.
• Issue final invoice/credit memo and send to patient with payment instructions.
• Submit any outstanding claims or appeals within agreed timelines and notify patient of status updates.
• Document and circulate any contingency financial agreements (payment plan, package rollover) and obtain signatures.
• Achieve shared, documented determination of outcome status relative to agreed success signals.
• Agree and document a clear, patient-approved clinical next step with owners and timeline.
• Ensure patient understands consequences (clinical, emotional, financial) and provides informed consent for the plan.
• Capture any urgent needs (e.g., early pregnancy monitoring or emergency escalation) and assign responsibility.
• Produce a one-page Outcome Summary comparing results to success signals and save to shared care plan.
• Schedule agreed follow-up appointments or referrals and confirm dates with the patient within 48 hours.
• Document patient consent and chosen plan in the medical record and send a patient-facing care summary.
• Open a benefits/financial follow-up if plan has additional costs and notify financial counselor.
• Case Snapshot (Current State)
• Identify root causes and separate patient-specific vs systemic issues.
• Define 2–4 actionable improvements with owners and measurable outcomes.
• Presentation of Clinical Outcomes
• Access, Privacy & Consent
• Follow-up Clinical Plan
• Timeline & Data Review
• Claims & Coverage Status
• Feedback vs Escalation Paths
• Consequence Assessment
• Administrative Handoff & Scheduling
• Patient Liability & Refunds/Credits
• Consequence & Impact Analysis
• Benefits & Coverage Clarification
• Channel Mechanics & Tools
• Contingency Financing Options
• Gap Analysis vs Agreed Success Signals
• Root Cause Identification
• Sign-offs & Documentation
• Psychosocial Support & Resources
• Improvement Options & Prioritization
• Options & Recommendation
• Reporting Cadence
• Patient Confirmation & Consent
• Confirm Communications Plan
• Decide Owners, Timeline, and Measurement